| [1］Duval M，Klein JP，He W，et al.Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure［J］.J Clin Oneol，2010，28：3730-3738. [2］张之南，沈悌.血液病诊断及疗效标准［M］.3版.北京：科学出版社，2007：116-121. [3］关于难治性急性白血病诊断标准的商讨纪要.第四届全国难治性白血病学术研讨会［J］.白血病·淋巴瘤，2004，13：70. [4］Thomas DA，Sarris AH，Cortes J，et al.Phasell study of sphingo-somal vincristine in patients with recurrentor refractory adult acute lymphocytic leukemia［J］.Cancer，2006，106：120-127. [5］Yamada K，Furusawa S，Saito K.Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously trea-ted acute myelogenous leukemia：a pilot study［J］.Leukemia，1995，9：10-14. [6］Li JM，Shen Y，Wu DP，et al.Aclarubicin and low-dose Cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome：a multicenter study of 112 Chinese patients［J］.Int J Hematol，2005，82：48-54. [7］杨永，计成阜，张彦明，等.IAG预激方案治疗复发、难治性急性髓系白血病临床分析［J］.中华血液学杂志，2013，34：637-638. [8］He GS，Zhang X，Wu DP，et al.Outcomes of CAG regimen for refractory biphenotypic acute leukemia patients［J］.Chin Med Sci J，2009，24：178-181. [9］Xue SL，Wu DP，Sun AN，et al.CAG regimen enables relapsed or refractory T-cell acute Lymphocytic leukemia patients to achieve complete remission：a report of six cases［J］.Am J Hematol，2008，83：167-170. [10］Bai A，Kojima H，Hori M，et al.priming with G-CSF effectively enhanes low-dose Ara-c-induced in vivo apoptosis in myeloid leukmeia cells［J］.Exp Hematol，1999，27(2)：259-265. |
